See also this year's filing and all EDGAR filings for this company.
PDF Report 0001103021_2022_BIODELIVERY_SCIENCES_INTERNATIONAL_INC.pdf
Logs
info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001103021, BIODELIVERY SCIENCES INTERNATIONAL INC
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 202,065,000 |
1 | IntangibleAssetsNetIncludingGoodwill | 2,715,000 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 119,816,000 |
4 | LiabilitiesCurrent | 82,378,000 |
5 | LiabilitiesNoncurrent | 219,000 |
6 | remainder_Liabilities | 54,177,000 |
7 | CostOfGoodsAndServicesSold | 23,373,000 |
8 | SellingGeneralAndAdministrativeExpense | 106,206,000 |
9 | ResearchAndDevelopmentExpense | 0 |
10 | remainder_Expenses | -55,238,000 |
11 | remainder_Revenues | 166,703,000 |
12 | remainder_NetIncome | -7,502,000 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 324,596,000 |
1 | Liabilities | 136,774,000 |
2 | Expenses | 74,341,000 |
3 | Revenues | 166,703,000 |
4 | StockholdersEquity | 187,822,000 |
5 | NetIncome | 84,860,000 |
6 | ComprehensiveNetIncome | 84,860,000 |
7 | BaseVar | 354,958,000 |
8 | EconomicCapitalRatio | 1.77 |